{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:52:50Z","timestamp":1775915570566,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ijantimicag.2017.02.011","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T12:17:12Z","timestamp":1493295432000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp."],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-9018","authenticated-orcid":false,"given":"George","family":"Tetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cynamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Vikina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Tetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0010","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.02.011_bib0015","article-title":"Changing patterns and trends in systemic fungal infections","volume":"56","author":"Richardson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3684","article-title":"The mycobiota: interactions between commensal fungi and the host immune system","volume":"14","author":"Underhill","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.02.011_bib0025","article-title":"Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients","volume":"66","author":"Pagano","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09059180.00001011","article-title":"Pulmonary aspergillosis: a clinical review","volume":"20","author":"Kousha","year":"2011","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","article-title":"Aspergillus infections in transplant recipients","volume":"18","author":"Singh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2049-6958-8-59","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"8","author":"Tutar","year":"2013","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0060","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s10096-015-2474-y","article-title":"Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship","volume":"34","author":"Noni","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2180-14-53","article-title":"Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa","volume":"14","author":"Manavathu","year":"2014","journal-title":"BMC Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.02.011_bib0080","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1569-1993(16)30077-7","article-title":"WS03.6 study of Mul-1867, a drug candidate for inhalation therapy of pulmonary exacerbations in patients with cystic fibrosis against mixed infections caused by clinical isolates of P. aeruginosa, S. aureus and C. albicans in murine lung infection model","volume":"15","author":"Tetz","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0085","doi-asserted-by":"crossref","DOI":"10.1099\/jmmcr.0.000061","article-title":"Scedosporium apiospermum: a fungal pathogen causing pneumonia in a patient with cystic fibrosis","author":"Schwarz","year":"2015","journal-title":"JMM Case Rep"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/mmy\/myv119","article-title":"Chronic Aspergillus fumigatus colonization of the pediatric cystic fibrosis airway is common and may be associated with a more rapid decline in lung function","volume":"54","author":"Saunders","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019729","article-title":"Fungal biofilms, drug resistance, and recurrent infection","volume":"4","author":"Desai","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0966-842X(02)00002-1","article-title":"Candida biofilms and their role in infection","volume":"11","author":"Douglas","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0105","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/AAC.00234-08","article-title":"Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells","volume":"52","author":"Seidler","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0110","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.00471-08","article-title":"Effect of DNase and antibiotics on biofilm characteristics","volume":"53","author":"Tetz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0115","doi-asserted-by":"crossref","first-page":"e1005828","DOI":"10.1371\/journal.ppat.1005828","article-title":"Fungal super glue: the biofilm matrix and its composition, assembly, and functions","volume":"12","author":"Mitchell","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0120","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0125","article-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0130","article-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1358\/dnp.2010.23.2.1400855","article-title":"EUCAST breakpoints for antifungals","volume":"23","author":"Rodriguez-Tudela","year":"2010","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0140","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.02661-13","article-title":"Susceptibility breakpoints for amphotericin B and Aspergillus species in an in vitro pharmacokinetic\u2013pharmacodynamic model simulating free-drug concentrations in human serum","volume":"58","author":"Elefanti","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0145","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/1469-0691.12440","volume":"20","author":"Orasch","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0150","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0155","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/AEM.66.3.1249-1251.2000","article-title":"Characterization of fungal biofilms within a municipal water distribution system","volume":"66","author":"Doggett","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13756-015-0088-x","article-title":"In vitro antimicrobial activity of a novel compound, Mul-1867, against clinically important bacteria","volume":"4","author":"Tetz","year":"2015","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0165","article-title":"Quantitation of DNA and RNA","author":"Barbas","year":"2007","journal-title":"CSH Protoc"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5772\/59346","article-title":"Impact of silver nanoparticles on haemolysis, platelet function and coagulation","volume":"1","author":"Laloy","year":"2014","journal-title":"Nanobiomedicine"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0175","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/labinvest.2010.58","article-title":"Anticancer effects of CAMEL peptide","volume":"90","author":"Smolarczyk","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0180","first-page":"e50166","article-title":"Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs","volume":"73","author":"Evans","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tim.2011.07.004","article-title":"Importance of Candida\u2013bacterial polymicrobial biofilms in disease","volume":"19","author":"Harriott","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0190","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/EC.00287-12","article-title":"Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms","volume":"12","author":"Rajendran","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0195","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1099\/jmm.0.46569-0","article-title":"Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance","volume":"55","author":"Al-Fattani","year":"2006","journal-title":"J Med Microbiol"},{"issue":"1 Suppl.","key":"10.1016\/j.ijantimicag.2017.02.011_bib0200","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10096-004-1108-6","article-title":"Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy","volume":"23","author":"Groll","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1060028015621916","article-title":"New inhaled antimicrobial formulations for use in the cystic fibrosis patient population","volume":"50","author":"Campbell","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12890-016-0202-8","article-title":"The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review","volume":"16","author":"Russell","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0220","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.TP.0000101516.08327.A9","article-title":"Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients","volume":"77","author":"Drew","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0225","doi-asserted-by":"crossref","first-page":"376287","DOI":"10.1155\/2010\/376287","article-title":"Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"2010","author":"Proesmans","year":"2010","journal-title":"Int J Pediatr"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0230","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1567-1364.2007.00347.x","article-title":"Characteristics of biofilm formation by Candida tropicalis and antifungal resistance","volume":"8","author":"Bizerra","year":"2008","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tri.12679","article-title":"10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation","volume":"29","author":"Peghin","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0240","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1099\/jmm.0.2008\/003350-0","article-title":"Polyhexamethylene guanidine hydrochloride-based disinfectant: a novel tool to fight methicillin-resistant Staphylococcus aureus and nosocomial infections","volume":"57","author":"Oul\u00e9","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0245","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.3390\/ijms14059906","article-title":"Cationic antimicrobial polymers and their assemblies","volume":"14","author":"Carmona-Ribeiro","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0250","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2191-0855-3-54","article-title":"Phenyl aldehyde and propanoids exert multiple sites of action towards cell membrane and cell wall targeting ergosterol in Candida albicans","volume":"3","author":"Khan","year":"2013","journal-title":"AMB Express"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0255","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.2042-7158.1964.tb07384.x","article-title":"Some aspects of the mode of action of chlorhexidine","volume":"16","author":"Hugo","year":"1964","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0260","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1099\/jmm.0.000017","article-title":"Is polyhexamethylene-guanidine hydrochloride (PHMGH) sporicidal? A critical review","volume":"64","author":"Brill","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.02.011_bib0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12941-016-0134-4","article-title":"Antimicrobial activity of Mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa","volume":"15","author":"Tetz","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791730136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791730136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T05:24:09Z","timestamp":1535865849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791730136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S092485791730136X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.02.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp.","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}